INDUSTRY OVERVIEW
The Plant-based Vaccines is Growing at 20% and is expected to reach 5Billion by 2031. Below mentioned are some of the dynamics shaping the Plant-based Vaccines .Plant-based Vaccines Market Size in (USD Billion) CAGR Growth Rate 20%
| Study Period | 2019-2031 |
| Market Size (2023): | 2Billion |
| Market Size (2031): | 5Billion |
| CAGR (2023 - 2031): | 20% |
| Fastest Growing Region | Asia Pacific |
| Domination Region | North America |
www.www.htfmarketinsights.com
Plant-based vaccines are made using recombinant technology, which involves integrating the gene encoding the required antigen protein into the plant genome. For gene transfer and transformation, the Agrobacterium tumefaciens is often utilized. Novel methods for transformation, including sonication, biolistic bombardment, PEG-mediated, and electroporation, are being used as technology advances.
Need More Details on Market Players and Competitors?
DOWNLOAD Sample Report
Market Drivers:
The key drivers in the market include technological advancements, increasing demand by consumers for innovative products, and government-friendly policies. Our research company combines industry reports with expert interviews and market analysis tools to identify and quantify drivers such as these. We review the current trends and gather data from leading industry publications and market research firms to decipher exactly how these and other factors are encouraging or dampening market growth.
- Plant-Based Vaccines Are Produced On A Large Scale And Are Cost-Effective
Market Restraints:
Some of the restraints to market growth may include regulatory challenges, high production costs, and disruptions in the supply chain. Our sources for these limitations include the regulation filings, industry surveys, and direct contributions from active participants within this marketplace. Tracking policy updates and economic reports further helps us to determine what kind of effect these factors have on the industry.
- Regulatory Approval
Trends in the Market:
Among the trending ones are sustainability, digital transformation, and increasing importance of data analytics. Our research company is tracking these trends through the use of trend analysis tools, social media sentiment analysis, and industry benchmarking studies. Insights in emerging market preferences and technological advancements also come from surveys and focus groups.
- Healthcare
These include emerging markets, innovation in product development, and strategic partnerships. We identify these opportunities by performing market segmentation analysis, competitive landscape assessment, and investment trend evaluation. The data is collected based on industry reports, financial performance analysis for major players, and forecasting models for identifying future growth areas.
- Rapid Diagnostics Of Infectious Diseases
Check Out Prices
Get Price
Regulation Shaping the Healthcare Industry
The healthcare industry is significantly influenced by a complex framework of regulations designed to ensure patient safety, efficacy of treatments, and the overall quality of care. Key regulatory areas include drug approval processes, medical device standards, and healthcare data protection. These regulations aim to maintain high standards for clinical practices and safeguard public health.Major Regulatory Bodies Worldwide
1. U.S. Food and Drug Administration (FDA): In the United States, the FDA is a pivotal regulatory authority overseeing the approval and monitoring of pharmaceuticals, medical devices, and biologics. The FDA sets stringent standards for product safety and efficacy, which significantly impacts market entry and ongoing compliance for healthcare companies.2. European Medicines Agency (EMA): The EMA plays a crucial role in the European Union, evaluating and supervising medicinal products. It provides centralized approval for drugs and ensures that products meet rigorous safety and efficacy standards across member states.
3. Health Canada: This agency regulates pharmaceuticals and medical devices in Canada, ensuring that products are safe, effective, and of high quality. Health Canada's regulations are aligned with international standards but tailored to meet national health needs.
4. World Health Organization (WHO): While not a regulatory body in the traditional sense, the WHO sets international health standards and provides guidelines that influence national regulatory frameworks. It plays a key role in global health policy and emergency response.
5. National Medical Products Administration (NMPA): In China, the NMPA regulates the approval and supervision of drugs and medical devices, with an increasing focus on aligning with global standards and facilitating market access.
Request for Customization
Get Customization
SWOT Analysis in the Healthcare Industry
SWOT analysis in the healthcare industry involves a structured assessment of Strengths, Weaknesses, Opportunities, and Threats to identify strategic advantages and areas for improvement.• Strengths: Evaluates internal factors such as advanced technology, skilled personnel, and strong brand reputation. For example, a hospital with cutting-edge medical equipment and specialized staff is considered to have a strong competitive edge.
• Weaknesses: Identifies internal limitations like outdated facilities, regulatory compliance issues, or high operational costs. Weaknesses could include inefficient processes or lack of innovation.
• Opportunities: Assesses external factors that could drive growth, such as emerging medical technologies, expanding markets, or favorable government policies. Opportunities might involve partnerships or new service lines.
• Threats: Examines external challenges such as increasing competition, changing regulations, or economic downturns. Threats might include new entrants with disruptive technologies or stricter regulatory requirements.
Market Segmentation
Segmentation by Type
- mRNA
- Recombinant
- Inactivated
- Viral
Plant-based Vaccines Market Segmentation by Type
www.htfmarketinsights.com
Segmentation by Application
- Pharmaceuticals
- Healthcare
- Biotechnology
- Public Health
- Research
Plant-based Vaccines Market Segmentation by Application
www.htfmarketinsights.com
Regional Outlook
The North America currently holds a significant share of the market, primarily due to several key factors: increasing consumption rates, a burgeoning population, and robust economic momentum. These elements collectively drive demand, positioning this region as a leader in the market. On the other hand, Asia Pacific is rapidly emerging as the fastest-growing area within the industry. This remarkable growth can be attributed to swift infrastructure development, the expansion of various industrial sectors, and a marked increase in consumer demand. These dynamics make this region a crucial player in shaping future market growth. In our report, we cover a comprehensive analysis of the regions and countries, includingRegions
- North America
- LATAM
- West Europe
- Central & Eastern Europe
- Northern Europe
- Southern Europe
- East Asia
- Southeast Asia
- South Asia
- Central Asia
- Oceania
- MEA
Fastest Growing Region
Asia Pacific
Dominating Region
North America
The company consistently allocates significant resources to expand its research capabilities, develop new medical technologies, and enhance its pharmaceutical portfolio. Johnson & Johnson's investments in R&D, coupled with strategic acquisitions and partnerships, reinforce its position as a major contributor to advancements in healthcare. This focus on innovation and market expansion underscores the critical importance of the North American region in the global healthcare landscape.
- Medicago (Canada)
- GlaxoSmithKline (United Kingdom)
- Creative Biolabs (United States)
- iBio (United States)
- Fraunhofer (Germany)
- ICON (Ireland)
- Mitsubishi Tanabe (Japan)
- Protalix (Israel)
- Kentucky Bioprocessing
- Inc. (United States)
Plant-based Vaccines Market Segmentation by Players
www.htfmarketinsights.com
Primary and Secondary Research
Primary research involves the collection of original data directly from sources in the healthcare industry. Approaches include the survey of health professionals, interviews with patients, focus groups, and clinical trials. This gives an overview of the current practice, the needs of the patient, and the interest in emerging trends. Firsthand information on the efficacy of new treatments, an assessment of market demand, and insight into changes in regulation can be sought only with primary research.Secondary Research: This is the investigation of existing information from a variety of sources, which may include industry reports, academic journals, government publications, and market research studies. Alfred secondary research empowers them to understand trends within industries, historical data, and competitive landscapes. It gives a wide view of the market dynamics and validates findings obtained from primary research. By combining both primary and secondary together, health organizations will be empowered to develop comprehensive strategies and make informed decisions based on a strong foundation built on data.
Report Infographics
|
Report Features |
Details |
|
Base Year |
2023 |
|
Based Year Market Size (2023) |
2Billion |
|
Historical Period |
2019 to 2023 |
|
CAGR (2023 to 2031) |
20% |
|
Forecast Period |
2023 to 2031 |
|
Forecasted Period Market Size (2031) |
5Billion |
|
Scope of the Report |
mRNA, Recombinant, Inactivated, Viral, Pharmaceuticals, Healthcare, Biotechnology, Public Health, Research. Sales Channel |
|
Regions Covered |
North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA |
|
Companies Covered |
Medicago (Canada), GlaxoSmithKline (United Kingdom) , Creative Biolabs (United States), iBio (United States), Fraunhofer (Germany), ICON (Ireland), Mitsubishi Tanabe (Japan), Protalix (Israel), Kentucky Bioprocessing, Inc. (United States) |
|
Customization Scope |
15% Free Customization (For EG) |
|
Delivery Format |
PDF and Excel through Email |
Plant-based Vaccines - Table of Contents
Chapter 1: Market Preface
- 1.1 Global Plant-based Vaccines Market Landscape
- 1.2 Scope of the Study
- 1.3 Relevant Findings & Stakeholder Advantages
Chapter 2: Strategic Overview
- 2.1 Global Plant-based Vaccines Market Outlook
- 2.2 Total Addressable Market versus Serviceable Market
- 2.3 Market Rivalry Projection
Chapter 3 : Global Plant-based Vaccines Market Business Environment & Changing Dynamics
-
3.1 Growth Drivers
- 3.1.1 Plant-Based Vaccines are Produced on a Large Scale and are Cost-Effective
-
3.2 Available Opportunities
- 3.2.1 Rapid Diagnostics of Infectious Diseases
- 3.2.2 Increase in Cases of Influenza
-
3.3 Influencing Trends
- 3.3.1 Healthcare
- 3.3.2 biotechnology
-
3.4 Challenges
- 3.4.1 Regulatory approval
- 3.4.2 technological challenges
- 3.5 Regional Dynamics
Need only Qualitative Analysis? Get Prices
Sectional Purchase
Chapter 4 : Global Plant-based Vaccines Industry Factors Assessment
- 4.1 Current Scenario
- 4.2 PEST Analysis
- 4.3 Business Environment - PORTER 5-Forces Analysis
- 4.3.1 Supplier Leverage
- 4.3.2 Bargaining Power of Buyers
- 4.3.3 Threat of Substitutes
- 4.3.4 Threat from New Entrant
- 4.3.5 Market Competition Level
- 4.4 Roadmap of Plant-based Vaccines Market
- 4.5 Impact of Macro-Economic Factors
- 4.6 Market Entry Strategies
- 4.7 Political and Regulatory Landscape
- 4.8 Supply Chain Analysis
Chapter 5: Plant-based Vaccines : Competition Benchmarking & Performance Evaluation
- 5.1 Global Plant-based Vaccines Market Concentration Ratio
- 5.1.1 CR4, CR8 and HH Index
- 5.1.2 % Market Share - Top 3
- 5.1.3 Market Holding by Top 5
- 5.2 Market Position of Manufacturers by Plant-based Vaccines Revenue 2023
- 5.3 Global Plant-based Vaccines Sales Volume by Manufacturers (2023)
- 5.4 BCG Matrix
- 5.4 Market Entropy
- 5.5 Heat Map Analysis
- 5.6 Strategic Group Analysis
Chapter 6: Global Plant-based Vaccines Market: Company Profiles
- 6.1 Medicago (Canada)
- 6.1.1 Medicago (Canada) Company Overview
- 6.1.2 Medicago (Canada) Product/Service Portfolio & Specifications
- 6.1.3 Medicago (Canada) Key Financial Metrics
- 6.1.4 Medicago (Canada) SWOT Analysis
- 6.1.5 Medicago (Canada) Development Activities
- 6.2 GlaxoSmithKline (United Kingdom)
- 6.3 Creative Biolabs (United States)
- 6.4 IBio (United States)
- 6.5 Fraunhofer (Germany)
- 6.6 ICON (Ireland)
- 6.7 Mitsubishi Tanabe (Japan)
- 6.8 Protalix (Israel)
- 6.9 Kentucky Bioprocessing
- 6.10 Inc. (United States)
- 6.11
To View a Complete List of Players? Inquiry Now
Sectional Purchase
Chapter 7 : Global Plant-based Vaccines by Type & Application (2019-2031)
-
7.1 Global Plant-based Vaccines Market Revenue Analysis (USD Million) by Type (2019-2023)
- 7.1.1 MRNA
- 7.1.2 Recombinant
- 7.1.3 Inactivated
- 7.1.4 Viral
- 7.1.5 Protein-based
-
7.2 Global Plant-based Vaccines Market Revenue Analysis (USD Million) by Application (2019-2023)
- 7.2.1 Pharmaceuticals
- 7.2.2 Healthcare
- 7.2.3 Biotechnology
- 7.2.4 Public Health
- 7.2.5 Research
- 7.3 Global Plant-based Vaccines Market Revenue Analysis (USD Million) by Type (2023-2031)
- 7.4 Global Plant-based Vaccines Market Revenue Analysis (USD Million) by Application (2023-2031)
Chapter 8 : North America Plant-based Vaccines Market Breakdown by Country, Type & Application
- 8.1 North America Plant-based Vaccines Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 8.1.1 United States
- 8.1.2 Canada
-
8.2 North America Plant-based Vaccines Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 8.2.1 MRNA
- 8.2.2 Recombinant
- 8.2.3 Inactivated
- 8.2.4 Viral
- 8.2.5 Protein-based
-
8.3 North America Plant-based Vaccines Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 8.3.1 Pharmaceuticals
- 8.3.2 Healthcare
- 8.3.3 Biotechnology
- 8.3.4 Public Health
- 8.3.5 Research
- 8.4 North America Plant-based Vaccines Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 8.5 North America Plant-based Vaccines Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 8.6 North America Plant-based Vaccines Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Looking for Section Purchase? Get Quote Now
Sectional Purchase
Chapter 9 : LATAM Plant-based Vaccines Market Breakdown by Country, Type & Application
- 9.1 LATAM Plant-based Vaccines Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 9.1.1 Brazil
- 9.1.2 Argentina
- 9.1.3 Chile
- 9.1.4 Mexico
- 9.1.5 Rest of LATAM
-
9.2 LATAM Plant-based Vaccines Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 9.2.1 MRNA
- 9.2.2 Recombinant
- 9.2.3 Inactivated
- 9.2.4 Viral
- 9.2.5 Protein-based
-
9.3 LATAM Plant-based Vaccines Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 9.3.1 Pharmaceuticals
- 9.3.2 Healthcare
- 9.3.3 Biotechnology
- 9.3.4 Public Health
- 9.3.5 Research
- 9.4 LATAM Plant-based Vaccines Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 9.5 LATAM Plant-based Vaccines Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 9.6 LATAM Plant-based Vaccines Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 10 : West Europe Plant-based Vaccines Market Breakdown by Country, Type & Application
- 10.1 West Europe Plant-based Vaccines Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 10.1.1 Germany
- 10.1.2 France
- 10.1.3 Benelux
- 10.1.4 Switzerland
- 10.1.5 Rest of West Europe
-
10.2 West Europe Plant-based Vaccines Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 10.2.1 MRNA
- 10.2.2 Recombinant
- 10.2.3 Inactivated
- 10.2.4 Viral
- 10.2.5 Protein-based
-
10.3 West Europe Plant-based Vaccines Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 10.3.1 Pharmaceuticals
- 10.3.2 Healthcare
- 10.3.3 Biotechnology
- 10.3.4 Public Health
- 10.3.5 Research
- 10.4 West Europe Plant-based Vaccines Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 10.5 West Europe Plant-based Vaccines Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 10.6 West Europe Plant-based Vaccines Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 11 : Central & Eastern Europe Plant-based Vaccines Market Breakdown by Country, Type & Application
- 11.1 Central & Eastern Europe Plant-based Vaccines Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 11.1.1 Bulgaria
- 11.1.2 Poland
- 11.1.3 Hungary
- 11.1.4 Romania
- 11.1.5 Rest of CEE
-
11.2 Central & Eastern Europe Plant-based Vaccines Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 11.2.1 MRNA
- 11.2.2 Recombinant
- 11.2.3 Inactivated
- 11.2.4 Viral
- 11.2.5 Protein-based
-
11.3 Central & Eastern Europe Plant-based Vaccines Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 11.3.1 Pharmaceuticals
- 11.3.2 Healthcare
- 11.3.3 Biotechnology
- 11.3.4 Public Health
- 11.3.5 Research
- 11.4 Central & Eastern Europe Plant-based Vaccines Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 11.5 Central & Eastern Europe Plant-based Vaccines Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 11.6 Central & Eastern Europe Plant-based Vaccines Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 12 : Northern Europe Plant-based Vaccines Market Breakdown by Country, Type & Application
- 12.1 Northern Europe Plant-based Vaccines Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 12.1.1 The United Kingdom
- 12.1.2 Sweden
- 12.1.3 Norway
- 12.1.4 Baltics
- 12.1.5 Ireland
- 12.1.6 Rest of Northern Europe
-
12.2 Northern Europe Plant-based Vaccines Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 12.2.1 MRNA
- 12.2.2 Recombinant
- 12.2.3 Inactivated
- 12.2.4 Viral
- 12.2.5 Protein-based
-
12.3 Northern Europe Plant-based Vaccines Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 12.3.1 Pharmaceuticals
- 12.3.2 Healthcare
- 12.3.3 Biotechnology
- 12.3.4 Public Health
- 12.3.5 Research
- 12.4 Northern Europe Plant-based Vaccines Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 12.5 Northern Europe Plant-based Vaccines Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 12.6 Northern Europe Plant-based Vaccines Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 13 : Southern Europe Plant-based Vaccines Market Breakdown by Country, Type & Application
- 13.1 Southern Europe Plant-based Vaccines Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 13.1.1 Spain
- 13.1.2 Italy
- 13.1.3 Portugal
- 13.1.4 Greece
- 13.1.5 Rest of Southern Europe
-
13.2 Southern Europe Plant-based Vaccines Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 13.2.1 MRNA
- 13.2.2 Recombinant
- 13.2.3 Inactivated
- 13.2.4 Viral
- 13.2.5 Protein-based
-
13.3 Southern Europe Plant-based Vaccines Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 13.3.1 Pharmaceuticals
- 13.3.2 Healthcare
- 13.3.3 Biotechnology
- 13.3.4 Public Health
- 13.3.5 Research
- 13.4 Southern Europe Plant-based Vaccines Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 13.5 Southern Europe Plant-based Vaccines Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 13.6 Southern Europe Plant-based Vaccines Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 14 : East Asia Plant-based Vaccines Market Breakdown by Country, Type & Application
- 14.1 East Asia Plant-based Vaccines Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 14.1.1 China
- 14.1.2 Japan
- 14.1.3 South Korea
- 14.1.4 Taiwan
- 14.1.5 Others
-
14.2 East Asia Plant-based Vaccines Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 14.2.1 MRNA
- 14.2.2 Recombinant
- 14.2.3 Inactivated
- 14.2.4 Viral
- 14.2.5 Protein-based
-
14.3 East Asia Plant-based Vaccines Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 14.3.1 Pharmaceuticals
- 14.3.2 Healthcare
- 14.3.3 Biotechnology
- 14.3.4 Public Health
- 14.3.5 Research
- 14.4 East Asia Plant-based Vaccines Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 14.5 East Asia Plant-based Vaccines Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 14.6 East Asia Plant-based Vaccines Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 15 : Southeast Asia Plant-based Vaccines Market Breakdown by Country, Type & Application
- 15.1 Southeast Asia Plant-based Vaccines Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 15.1.1 Vietnam
- 15.1.2 Singapore
- 15.1.3 Thailand
- 15.1.4 Malaysia
- 15.1.5 Indonesia
- 15.1.6 Philippines
- 15.1.7 Rest of SEA Countries
-
15.2 Southeast Asia Plant-based Vaccines Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 15.2.1 MRNA
- 15.2.2 Recombinant
- 15.2.3 Inactivated
- 15.2.4 Viral
- 15.2.5 Protein-based
-
15.3 Southeast Asia Plant-based Vaccines Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 15.3.1 Pharmaceuticals
- 15.3.2 Healthcare
- 15.3.3 Biotechnology
- 15.3.4 Public Health
- 15.3.5 Research
- 15.4 Southeast Asia Plant-based Vaccines Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 15.5 Southeast Asia Plant-based Vaccines Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 15.6 Southeast Asia Plant-based Vaccines Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 16 : South Asia Plant-based Vaccines Market Breakdown by Country, Type & Application
- 16.1 South Asia Plant-based Vaccines Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 16.1.1 India
- 16.1.2 Bangladesh
- 16.1.3 Others
-
16.2 South Asia Plant-based Vaccines Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 16.2.1 MRNA
- 16.2.2 Recombinant
- 16.2.3 Inactivated
- 16.2.4 Viral
- 16.2.5 Protein-based
-
16.3 South Asia Plant-based Vaccines Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 16.3.1 Pharmaceuticals
- 16.3.2 Healthcare
- 16.3.3 Biotechnology
- 16.3.4 Public Health
- 16.3.5 Research
- 16.4 South Asia Plant-based Vaccines Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 16.5 South Asia Plant-based Vaccines Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 16.6 South Asia Plant-based Vaccines Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 17 : Central Asia Plant-based Vaccines Market Breakdown by Country, Type & Application
- 17.1 Central Asia Plant-based Vaccines Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 17.1.1 Kazakhstan
- 17.1.2 Tajikistan
- 17.1.3 Others
-
17.2 Central Asia Plant-based Vaccines Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 17.2.1 MRNA
- 17.2.2 Recombinant
- 17.2.3 Inactivated
- 17.2.4 Viral
- 17.2.5 Protein-based
-
17.3 Central Asia Plant-based Vaccines Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 17.3.1 Pharmaceuticals
- 17.3.2 Healthcare
- 17.3.3 Biotechnology
- 17.3.4 Public Health
- 17.3.5 Research
- 17.4 Central Asia Plant-based Vaccines Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 17.5 Central Asia Plant-based Vaccines Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 17.6 Central Asia Plant-based Vaccines Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 18 : Oceania Plant-based Vaccines Market Breakdown by Country, Type & Application
- 18.1 Oceania Plant-based Vaccines Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 18.1.1 Australia
- 18.1.2 New Zealand
- 18.1.3 Others
-
18.2 Oceania Plant-based Vaccines Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 18.2.1 MRNA
- 18.2.2 Recombinant
- 18.2.3 Inactivated
- 18.2.4 Viral
- 18.2.5 Protein-based
-
18.3 Oceania Plant-based Vaccines Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 18.3.1 Pharmaceuticals
- 18.3.2 Healthcare
- 18.3.3 Biotechnology
- 18.3.4 Public Health
- 18.3.5 Research
- 18.4 Oceania Plant-based Vaccines Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 18.5 Oceania Plant-based Vaccines Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 18.6 Oceania Plant-based Vaccines Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 19 : MEA Plant-based Vaccines Market Breakdown by Country, Type & Application
- 19.1 MEA Plant-based Vaccines Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 19.1.1 Turkey
- 19.1.2 South Africa
- 19.1.3 Egypt
- 19.1.4 UAE
- 19.1.5 Saudi Arabia
- 19.1.6 Israel
- 19.1.7 Rest of MEA
-
19.2 MEA Plant-based Vaccines Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 19.2.1 MRNA
- 19.2.2 Recombinant
- 19.2.3 Inactivated
- 19.2.4 Viral
- 19.2.5 Protein-based
-
19.3 MEA Plant-based Vaccines Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 19.3.1 Pharmaceuticals
- 19.3.2 Healthcare
- 19.3.3 Biotechnology
- 19.3.4 Public Health
- 19.3.5 Research
- 19.4 MEA Plant-based Vaccines Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 19.5 MEA Plant-based Vaccines Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 19.6 MEA Plant-based Vaccines Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 20: Research Findings & Conclusion
- 20.1 Key Findings
- 20.2 Conclusion
Chapter 21: Methodology and Data Source
-
21.1 Research Methodology & Approach
- 21.1.1 Research Program/Design
- 21.1.2 Market Size Estimation
- 21.1.3 Market Breakdown and Data Triangulation
-
21.2 Data Source
- 21.2.1 Secondary Sources
- 21.2.2 Primary Sources
Chapter 22: Appendix & Disclaimer
- 22.1 Acronyms & bibliography
- 22.2 Disclaimer
Frequently Asked Questions (FAQ):
The Plant-based Vaccines market is estimated to derive a market size of 5Billion by 2031.
The Plant-based Vaccines Market is estimated to grow at a CAGR of 20%, currently pegged at 2Billion.
Healthcare, Biotechnology are seen to make big Impact on Plant-based Vaccines Market Growth.
The leaders in the Global Plant-based Vaccines Market such as Medicago (Canada), GlaxoSmithKline (United Kingdom) , Creative Biolabs (United States), iBio (United States), Fraunhofer (Germany), ICON (Ireland), Mitsubishi Tanabe (Japan), Protalix (Israel), Kentucky Bioprocessing, Inc. (United States), are targeting innovative and differentiated growth drivers some of them are Plant-Based Vaccines Are Produced On A Large Scale And Are Cost-Effective,,
Rapid Development In Treatment Of Cancer
Some of the major roadblocks that industry players have identified are Regulatory Approval, Technological Challenges.
The market opportunity is clear from the flow of investment into Global Plant-based Vaccines Market, some of them are Rapid Diagnostics Of Infectious Diseases ,,
Increase In Cases Of Influenza.
Medicago (Canada), GlaxoSmithKline (United Kingdom) , Creative Biolabs (United States), iBio (United States), Fraunhofer (Germany), ICON (Ireland), Mitsubishi Tanabe (Japan), Protalix (Israel), Kentucky Bioprocessing, Inc. (United States), etc are the main players listed in the Global Plant-based Vaccines Market Study.
The Global Plant-based Vaccines Market Study is Broken down by applications such as Pharmaceuticals, Healthcare, Biotechnology, Public Health, Research.
The Global Plant-based Vaccines Market Study is segmented by mRNA, Recombinant, Inactivated, Viral, Protein-based.
The Global Plant-based Vaccines Market Study includes regional breakdown as North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA
Historical Year: 2019 - 2023; Base year: 2023; Forecast period: 2025 to 2031
Plant-based vaccines are made using recombinant technology, which involves integrating the gene encoding the required antigen protein into the plant genome. For gene transfer and transformation, the Agrobacterium tumefaciens is often utilized. Novel methods for transformation, including sonication, biolistic bombardment, PEG-mediated, and electroporation, are being used as technology advances.
